combination

HUTCHMED Highlights FRUSICA-2 Registration Trial Data to be Presented at the 2025 ESMO Congress

The fruquintinib and sintilimab combination demonstrated significant PFS improvements in advanced renal cell carcinoma patients after progression on first-line therapies…

6 days ago

Celanese Designing the Future at K 2025

New materials and services empower customers to accelerate design innovations, meet complex performance requirements, and advance sustainability goalsDALLAS--(BUSINESS WIRE)--$CE--Celanese Corporation…

2 weeks ago

XED Welcomes Back Technology Visionary Mrinal Srivastava as Chief Technology Officer

NEW YORK and MUMBAI, India, Sept. 26, 2025 /PRNewswire/ -- XED is proud to announce the return of Mrinal Srivastava as…

3 weeks ago

IndoSpace expands presence with new 66-Acre Park in Maharashtra’s industrial and warehousing hub, Bhiwandi

MUMBAI, India, Sept. 26, 2025 /PRNewswire/ -- IndoSpace, India's fully integrated supply chain infrastructure services platform, has launched its new logistics…

3 weeks ago

C4 Therapeutics Presents Cemsidomide Phase 1 Multiple Myeloma Data Supporting Potential Best-in-Class Profile at the International Myeloma Society Annual Meeting

September 20, 2025 11:00 ET  | Source: C4 Therapeutics, Inc. Cemsidomide in Combination With Dexamethasone Achieved a 50% Overall Response…

4 weeks ago

Nxera Pharma and Cancer Research UK Announce First Patient Dosed in Phase 2a Trial of Investigational Cancer Immunotherapy HTL0039732

HTL0039732 (also known as NXE0039732) is Nxera’s novel oral EP4 antagonist being investigated to treat a wide range of solid…

1 month ago

Olympism365: Six innovators awarded grants to advance UN SDGs through combination of sport and technology

16 September 2025 – Six recipients have received Tech365 Incubate grants, each worth up to USD 40,000, the International Olympic…

1 month ago

Anbogen Receives FDA Clearance to Initiate Phase 1/2 Trial of ABT-301 Triplet Therapy for Advanced Colorectal Cancer

TAIPEI, Aug. 4, 2025 /PRNewswire/ -- Anbogen Therapeutics today announced that the U.S. Food and Drug Administration (FDA) has approved…

2 months ago

A23 launches the 3rd season of Rummy Indian Open with a 25 Crore prize pool and a high-stakes finale in Goa

Spanning over two months, RIO is a combination of a tournament and a leaderboard culminating in an offline finale NEW…

2 months ago